New Mexico Cannabis Businesses Eye Tax Breaks After Federal Rescheduling
The 2026 cannabis tax break potential could significantly reduce operational costs for New Mexico cannabis businesses. Federal rescheduling from Schedule I to Schedule III would eliminate IRS Section 280E restrictions. This change may improve product…
Village Farms Opens Groningen Facility to Quintuple Dutch Cannabis Output
The large scale cannabis production facility in Groningen represents a major increase in Dutch medical cannabis output. This pharmaceutical-grade cultivation aims to improve product consistency and supply reliability. Patients may benefit from more…
Confusion Over Federal Medical Marijuana Rescheduling in Colorado
Federal medical marijuana rescheduling confusion is causing regulatory challenges in Colorado. This confusion impacts patient access and continuity of care. Clinicians must understand how these changes affect medical cannabis recommendations.
Israel and Lebanon Extend Ceasefire; Trump Eases Medical Marijuana Rules
Federal medical marijuana restrictions easing under Trump could expand patient access and improve clinical care continuity. These policy changes may reduce regulatory barriers affecting treatment options. Clinicians and patients should monitor these…
Marijuana Reclassification Means Big Changes for Oklahoma Businesses
Marijuana reclassification impact Oklahoma businesses by altering federal cannabis policies and regulatory frameworks. This shift could improve research access and standardization for cannabis products. Oklahoma's medical marijuana industry may…
Judge Dismisses Case Involving Puff Cannabis in Menominee County
Legal dismissals cannabis cases often reflect evolving regulatory frameworks that impact patient access to medical cannabis. A recent case involving Puff Cannabis in Menominee County was dismissed by a judge. Clinicians should understand how such legal…
Medical Marijuana Moves to Schedule III, Boosting Research and Tax Relief
Schedule III cannabis research is opening new doors for medical marijuana by reducing regulatory hurdles. This reclassification allows more rigorous clinical trials and tax relief for cannabis businesses. Patients may benefit from improved access and…
Marijuana Reclassified but Remains Illegal in Idaho — for Now
Idaho cannabis prohibition continues despite federal reclassification of marijuana. This legal conflict affects patient access and clinical decision-making in Idaho. Patients and clinicians face challenges due to the state’s strict cannabis laws.
Marijuana Reclassified to Schedule 3: Clinical, Research, and Coverage Implications
Marijuana reclassified schedule 3 removes regulatory barriers, enabling expanded clinical research. This shift may influence insurance coverage and banking access for cannabis businesses. Patients and clinicians should monitor evolving policies closely.
The U.S. Opens Its Medical Marijuana Market to Global Trade (For Now) – Harris Sliwoski
The U.S. is opening pathways for international medical marijuana trade, marking a significant federal policy shift. This change could impact access, pricing, and quality standards for patients. International trade may introduce new therapeutic products…